Real Estate - Services
Compare Stocks
2 / 10Stock Comparison
ASPS vs WELL
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
ASPS vs WELL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Real Estate - Services | REIT - Healthcare Facilities |
| Market Cap | $78M | $151.66B |
| Revenue (TTM) | $175M | $11.63B |
| Net Income (TTM) | $6M | $1.43B |
| Gross Margin | 27.8% | 39.1% |
| Operating Margin | 3.7% | 4.4% |
| Forward P/E | 46.2x | 79.7x |
| Total Debt | $192M | $21.38B |
| Cash & Equiv. | $27M | $5.03B |
ASPS vs WELL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Altisource Portfoli… (ASPS) | 100 | 6.1 | -93.9% |
| Welltower Inc. (WELL) | 100 | 427.2 | +327.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ASPS vs WELL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ASPS is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta -0.33, current ratio 25.55x
- Beta -0.33, current ratio 25.55x
- Lower P/E (46.2x vs 79.7x)
WELL carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 2 yrs, beta 0.13, yield 1.3%
- Rev growth 35.8%, EPS growth -11.5%, 3Y rev CAGR 22.7%
- 233.9% 10Y total return vs ASPS's -97.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 35.8% FFO/revenue growth vs ASPS's 6.8% | |
| Value | Lower P/E (46.2x vs 79.7x) | |
| Quality / Margins | 12.3% margin vs ASPS's 3.6% | |
| Dividends | 1.3% yield; 2-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | +45.8% vs ASPS's -8.3% | |
| Efficiency (ROA) | 4.5% ROA vs WELL's 2.3%, ROIC 11.5% vs 0.5% |
ASPS vs WELL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ASPS vs WELL — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
WELL leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL is the larger business by revenue, generating $11.6B annually — 66.4x ASPS's $175M. WELL is the more profitable business, keeping 12.3% of every revenue dollar as net income compared to ASPS's 3.6%. On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $175M | $11.6B |
| EBITDAEarnings before interest/tax | $14M | $2.8B |
| Net IncomeAfter-tax profit | $6M | $1.4B |
| Free Cash FlowCash after capex | $4M | $2.5B |
| Gross MarginGross profit ÷ Revenue | +27.8% | +39.1% |
| Operating MarginEBIT ÷ Revenue | +3.7% | +4.4% |
| Net MarginNet income ÷ Revenue | +3.6% | +12.3% |
| FCF MarginFCF ÷ Revenue | +2.4% | +21.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +9.5% | +40.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +36.4% | +22.5% |
Valuation Metrics
ASPS leads this category, winning 3 of 3 comparable metrics.
Valuation Metrics
At 46.2x trailing earnings, ASPS trades at a 70% valuation discount to WELL's 155.7x P/E. On an enterprise value basis, ASPS's 16.3x EV/EBITDA is more attractive than WELL's 67.4x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $78M | $151.7B |
| Enterprise ValueMkt cap + debt − cash | $244M | $168.0B |
| Trailing P/EPrice ÷ TTM EPS | 46.20x | 155.73x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 79.69x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 16.34x | 67.37x |
| Price / SalesMarket cap ÷ Revenue | 0.46x | 14.22x |
| Price / BookPrice ÷ Book value/share | — | 3.40x |
| Price / FCFMarket cap ÷ FCF | — | 53.25x |
Profitability & Efficiency
ASPS leads this category, winning 5 of 7 comparable metrics.
Profitability & Efficiency
On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs ASPS's 6/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | — | +3.5% |
| ROA (TTM)Return on assets | +4.5% | +2.3% |
| ROICReturn on invested capital | +11.5% | +0.5% |
| ROCEReturn on capital employed | +158.5% | +0.6% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 7 |
| Debt / EquityFinancial leverage | — | 0.49x |
| Net DebtTotal debt minus cash | $166M | $16.3B |
| Cash & Equiv.Liquid assets | $27M | $5.0B |
| Total DebtShort + long-term debt | $192M | $21.4B |
| Interest CoverageEBIT ÷ Interest expense | -0.16x | 0.26x |
Total Returns (Dividends Reinvested)
WELL leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WELL five years ago would be worth $31,193 today (with dividends reinvested), compared to $1,265 for ASPS. Over the past 12 months, WELL leads with a +45.8% total return vs ASPS's -8.3%. The 3-year compound annual growth rate (CAGR) favors WELL at 43.3% vs ASPS's -41.7% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -0.6% | +16.2% |
| 1-Year ReturnPast 12 months | -8.3% | +45.8% |
| 3-Year ReturnCumulative with dividends | -80.2% | +194.0% |
| 5-Year ReturnCumulative with dividends | -87.4% | +211.9% |
| 10-Year ReturnCumulative with dividends | -97.2% | +233.9% |
| CAGR (3Y)Annualised 3-year return | -41.7% | +43.3% |
Risk & Volatility
Evenly matched — ASPS and WELL each lead in 1 of 2 comparable metrics.
Risk & Volatility
ASPS is the less volatile stock with a -0.33 beta — it tends to amplify market swings less than WELL's 0.13 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. WELL currently trades 98.6% from its 52-week high vs ASPS's 43.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.33x | 0.13x |
| 52-Week HighHighest price in past year | $15.96 | $219.59 |
| 52-Week LowLowest price in past year | $4.30 | $142.65 |
| % of 52W HighCurrent price vs 52-week peak | +43.4% | +98.6% |
| RSI (14)Momentum oscillator 0–100 | 54.9 | 57.6 |
| Avg Volume (50D)Average daily shares traded | 31K | 2.6M |
Analyst Outlook
WELL leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
WELL is the only dividend payer here at 1.28% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy |
| Price TargetConsensus 12-month target | — | $226.50 |
| # AnalystsCovering analysts | — | 34 |
| Dividend YieldAnnual dividend ÷ price | — | +1.3% |
| Dividend StreakConsecutive years of raises | 1 | 2 |
| Dividend / ShareAnnual DPS | — | $2.76 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.0% | 0.0% |
WELL leads in 3 of 6 categories (Income & Cash Flow, Total Returns). ASPS leads in 2 (Valuation Metrics, Profitability & Efficiency). 1 tied.
ASPS vs WELL: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is ASPS or WELL a better buy right now?
For growth investors, Welltower Inc.
(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus 6. 8% for Altisource Portfolio Solutions S. A. (ASPS). Altisource Portfolio Solutions S. A. (ASPS) offers the better valuation at 46. 2x trailing P/E, making it the more compelling value choice. Analysts rate Welltower Inc. (WELL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ASPS or WELL?
On trailing P/E, Altisource Portfolio Solutions S.
A. (ASPS) is the cheapest at 46. 2x versus Welltower Inc. at 155. 7x.
03Which is the better long-term investment — ASPS or WELL?
Over the past 5 years, Welltower Inc.
(WELL) delivered a total return of +211. 9%, compared to -87. 4% for Altisource Portfolio Solutions S. A. (ASPS). Over 10 years, the gap is even starker: WELL returned +233. 9% versus ASPS's -97. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ASPS or WELL?
By beta (market sensitivity over 5 years), Altisource Portfolio Solutions S.
A. (ASPS) is the lower-risk stock at -0. 33β versus Welltower Inc. 's 0. 13β — meaning WELL is approximately -140% more volatile than ASPS relative to the S&P 500.
05Which is growing faster — ASPS or WELL?
By revenue growth (latest reported year), Welltower Inc.
(WELL) is pulling ahead at 35. 8% versus 6. 8% for Altisource Portfolio Solutions S. A. (ASPS). On earnings-per-share growth, the picture is similar: Altisource Portfolio Solutions S. A. grew EPS 112. 0% year-over-year, compared to -11. 5% for Welltower Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ASPS or WELL?
Welltower Inc.
(WELL) is the more profitable company, earning 8. 8% net margin versus 0. 9% for Altisource Portfolio Solutions S. A. — meaning it keeps 8. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ASPS leads at 4. 6% versus 3. 3% for WELL. At the gross margin level — before operating expenses — WELL leads at 39. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Which pays a better dividend — ASPS or WELL?
In this comparison, WELL (1.
3% yield) pays a dividend. ASPS does not pay a meaningful dividend and should not be held primarily for income.
08Is ASPS or WELL better for a retirement portfolio?
For long-horizon retirement investors, Welltower Inc.
(WELL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 13), 1. 3% yield, +233. 9% 10Y return). Both have compounded well over 10 years (WELL: +233. 9%, ASPS: -97. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between ASPS and WELL?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: ASPS is a small-cap quality compounder stock; WELL is a mid-cap high-growth stock. WELL pays a dividend while ASPS does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.